Article Details

RSV: Safety, Efficacy and Tolerability of Palivizumab | DHPS - Dove Medical Press

Retrieved on: 2023-09-11 03:53:04

Tags for this article:

Click the tags to see associated articles and topics

RSV: Safety, Efficacy and Tolerability of Palivizumab | DHPS - Dove Medical Press. View article details on HISWAI: https://www.dovepress.com/review-of-the-safety-efficacy-and-tolerability-of-palivizumab-in-the-p-peer-reviewed-fulltext-article-DHPS

Excerpt

Suptavumab is another human monoclonal antibody developed for RSV-disease prophylaxis. However, in August 2017 Regeneron Pharmaceuticals discontinued ...

Article found on: www.dovepress.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up